I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

The high prevalence (20% to 30%) of dry socket and its associated discomfort and complications remain one of the most important concerns of the dental profession.\[[@ref1]--[@ref6]\] The etiology of alveolar osteitis (AO) is not clear but increased fibrinolytic activity in the extraction socket has been shown to be associated with the clot lyses and exposure of the bone to the oral cavity.\[[@ref4][@ref7]\] The increased fibrinolysis is thought to be attributed to surgery trauma, pathogenic fibrinolytics, enzymatic changes due to the inflammation, presence of high amounts of bacteria before and after surgery and other factors. The treatment is merely symptomatic and is limited to pain alleviation. Clinicians have attempted to observe preventive measures e.g. the administration of antifibrinolytics, antiseptics and antibiotics. These attempts, however, have not been uniformly successful due to the obscurity of the etiologic factors. Failure to prevent AO, on the other hand, will lead to clinical presentation of highly tender exposed bony surfaces, severe pain in the extraction site, moderate to severe dull headache with pain radiating to the ears in some instances, halitosis and altered taste.\[[@ref7]\]

The present study was conducted to assess the effect of autogenous PRGF applied postoperatively in the prevention of AO.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Inclusion and exclusion criteria {#sec2-1}
--------------------------------

Included were 40 patients with age range of 18 to 45 years. Bilateral (maxillary or mandibular) third molar extractions with similar scores of the Pederson scale of extraction difficulty and at least one AO risk factor (a history of pericoronitis, contraceptive uptake, smoking habits, bruxism or a history of AO) were chosen. Excluded were patients under antibiotic regimen or other interfering medications (e.g. steroids or antidepressants) at the time of the study. Also patients with complications during extraction, neurologic diseases, prophylactic needs, and lack of cooperation (e.g. patients who were not present for the follow-up sessions) were excluded. Impacted or partially impacted third molars were not excluded provided the difficulty of extraction was similar bilaterally. Venous blood samples were taken from patients prior to extraction.

PRGF preparation {#sec2-2}
----------------

Ten milliliters of blood was obtained from cephalic or basilic veins (due to their accessibility and sufficient diameter) using 19 gauge needle to avoid platelet rupture or activation in the lumen. Sampled blood was immediately transferred to a syringe containing anticoagulant (1 ml of 3.8% sodium citrate for 10 ml blood) and centrifuged in PRGF system (BTI, Vitoria, Spain), set for 460 G in 8 minutes, to sediment platelets. Three layers were isolated after centrifugation: Red blood cells (RBCs) at the bottom, white blood cells (WBCs) in the middle and plasma on the surface. The surface plasma itself contained three distinct layers \[[Figure 1](#F1){ref-type="fig"}\]. Platelet poor in growth factors (PPGF) on the top (500 μl), plasma growth factors (PGF) in the middle and PRGF at the bottom which contains the highest concentrations of platelets and growth factors accumulated right above the RBCs. PPGF and PGF were separately retrieved using two 500 μl pipettes. CaCl~2~ was then added to PRGF (0.05 ml per ml) and coagulation was obtained within 5 to 8 minutes. To decrease coagulation time, PRGF was placed on a thermal block prior to activation to reach body temperature (37°). Finally the formed gel was placed in the socket.\[[@ref8][@ref9]\]

![The comparative illustration of the pain intensity (mean ± standard deviation) felt by the patients (scored on VAS) on the second, the third and the fourth days following the third molar extraction. P2: PRGF group in the second day. C4: control group in the fourth day. Gray triangles represent PRGF group and the white ones represent control group](NJMS-3-38-g001){#F1}

Study process {#sec2-3}
-------------

This split-mouth, double-blind clinical trial was peer reviewed and approved by the local board of medical ethics and the research committee of the school of dental medicine. All extractions were performed by a single surgeon in order to standardize the level of surgical trauma. PRGF was blindly placed in one of the two bilateral sockets of each patient. These sockets were considered as the PRGF group (*n* = 20). The other socket in each patient was treated via placebo. These sockets were considered as the control group (*n* = 20). Sockets were examined 2, 3 and 4 days postoperatively by a blinded examiner to detect possible development of AO and pain was recorded on visual analogue scale (VAS). The scoring was as follows: 0 = no pain, 1--3 = mild pain, 4--6 = moderate pain, 6--8 = severe pain and 9 = pain with the highest possible severity. Healing was assessed on the third and the seventh days based on healing scale. The scale had 4 stages as follows: clot degeneration, wound departure with pus or without pus and no healing.\[[@ref10]\] Data were analyzed in SPSS v16 using the Wilcoxon test.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Patients were 22.1 ± 1.7 years old. The extraction sites were maxillary in half of the cases (20 patients, 40 sockets) and mandibular in the other half (20 patients, 40 sockets). Based on our questionnaire, 18 patients were smokers, 20 patients were bruxers, 15 patients had a history of pericoronitis, 9 patients had a history of AO and 10 patients were using contraceptive drugs.

Dry socket {#sec2-4}
----------

In the control group, 14 patients presented AO with no AO on the PRGF side. AO did not develop in the 22 patients on either side. Four patients developed AO on both sides. This was indicative of a statistically significant difference when PRGF was used (*P* \< 0.05).

Pain and healing {#sec2-5}
----------------

The intensity of pain though second, third and forth postoperative days is presented in [Figure 1](#F1){ref-type="fig"}. The intensity of post-extraction pain was significantly less in PRGF group compared to control group in (*P* \< 0.00 for each post-extraction day). [Figure 2](#F2){ref-type="fig"} represents the healing scores of the study group. The healing was significantly better in the PRGF group (*P* \< 0.00 for both assessment days).

![The comparative illustration of the healing scores (mean ± standard deviation) on the third and the seventh days following the third molar extraction. P3: PRGF group in the second day. C7: control group in the fourth day. Gray triangles represent PRGF group and the white ones represent control group](NJMS-3-38-g002){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The present study included 40 candidates of bilateral intra-arch third molar extraction (80 sockets). Included were cases with similar scores of the Pederson scale of difficulty of extraction and at least one AO predisposing factor.

Studies have shown that 0.2 ml of plasma located right above the red blood cells contains the highest concentrations of platelets, growth factors and fibrinogen.\[[@ref11]\] The application of PRGF in the extraction socket was associated with decreased occurrence of AO, decreased pain and discomfort and enhanced healing. Authors have reported the contributing effect of PRGF in healing after periodontal surgical or non-surgical managements.\[[@ref12]\] Consistent to the findings of the present study, Amitua *et al*.\[[@ref8]\] studied the application of PRGF in different oral surgeries and reported remarkable outcomes in terms of epithelial proliferation, wound healing and bone regeneration in periodontal defects which were candidates for implant therapy. In another study, decreased epithelialization time, decreased bone regeneration time and improved bone regeneration were observed when PRGF was applied in the extraction socket of third molar. Also no pain, infection or AO was observed with the application of PRGF.\[[@ref13]\] This was also in accordance to the results of the present study. Several studies have assessed the effect of PRP, on the healing and regeneration of the soft and hard tissues in different surgeries.\[[@ref12]--[@ref14]\] The coagulative effect of PRGF was most important. PRGF and PRP have the same platelet concentration which is the least concentration needed for clinical effects. (The PRP platelet concentration is 4--7 times more than the peripheral blood platelet concentration (200.000) and the PRGF platelet concentration is 8 times more than the peripheral blood in 0.5 cc above the RBCs and 4 times greater in the next layer.)\[[@ref9][@ref15]\]

Rutkowski *et al*.\[[@ref16]\] studied the effect of PRP on the prevention of AO after the extraction of 904 mandibular extractions. They claimed that the application of PRP decreases the occurrence of AO up to 60% seen in the high-risk patients. This value was 77% in the present study which is thought to be attributed to a higher efficacy of PRGF compared to PRP. The study of Rutkowski *et al*. did not include matched cases and was not case-control but the study population in the present split-mouth study was matched according to gender, age and difficulty of extraction.

Jerome *et al*.\[[@ref17]\] studied the preventive effect of PRP on AO following surgical removal of mandibular third molars of 117 patients. In their study, AO occurred in 3.4% of the PRP group and 12.8% of the control group. Also they noticed faster tissue healing, enhanced homeostasis and less swelling with the application of PRP.

PRGF does not need bovine or human thrombin for coagulation. Apart from the growth factors restored in the platelets, PRGF includes plasma proteins and coagulative factors and is then more advantageous compared to PRP.\[[@ref18]\] The pain relief and the healing rate increase due to the application of PRGF may be due to the inclusion of signaling proteins and platelet granules, which are immediately released with the activation of platelets and the initiation of coagulative cascade to form the clot. These factors are either synthesized by megakaryocytes or stored within the platelet granules or stored plasma proteins by endocytosis while circulating in blood cycle, because platelets do not have a nucleus and do not possess required elements for the production of these factors (insulin like growth factors, vascular endothelial growth factor, epidermal growth factor, nerve growth factor, transforming growth factor rho, cytokines like angiopoietin II and interleukin I).\[[@ref19]\]

These factors trigger differentiation, increase collagen synthesis, increase chemotaxis and other immune system cells to the surgery site and initiate angiogenesis. It also induces fibroblast proliferation, bone formation and bone regeneration.\[[@ref20]\] The application of PRGF may significantly prevent AO and its complications due to long-term angiogenetic effect and increased regenerability. Patients with bruxism are highly susceptible to AO because of high bone density and the consequent decreased blood supply. The angiogenetic effect of PRGF may reduce these complications in bruxers.\[[@ref16]\] Patients with a history of pericoronitis may be predisposed to AO.

PRGF also accelerates the bone and tissue healing rate.\[[@ref20]\]

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Our study shows that the application of PRGF will help prevent the AO formation especially in susceptible patients.
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